Concepedia

PD-1 blockade and lenalidomide combination therapy for chronic active Epstein-Barr virus infection

Yue Song, Jingshi Wang, Yini Wang, Lin Wu, Yahong You, Deli Song, Leilei Chen, Gaungqiang Meng, Xiaodan He, Tingting Cui,

Clinical Microbiology and Infection · 2023 · 18 citations · 17 references

DOIFull text

Open access

Concepts

References

17

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

Esra A. Akbay, Shohei Koyama, Julián Carretero et al. · Cancer Discovery · 2013 · 1.2K citations · Full text

Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent

Alice O. Kamphorst, Andreas Wieland, Tahseen H. Nasti et al. · Science · 2017 · 978 citations · Full text

Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients

Alice O. Kamphorst, Rathi N. Pillai, Shu Yang et al. · Proceedings of the National Academy of Sciences · 2017 · 847 citations · Full text

Clinical and virologic characteristics of chronic active Epstein-Barr virus infection

Hiroshi Kimura, Yo Hoshino, Hirokazu Kanegane et al. · Blood · 2001 · 425 citations · Full text

Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

Güllü Görgün, Mehmet Samur, Kristen Cowens et al. · Clinical Cancer Research · 2015 · 299 citations · Full text